Subsets of mesenchymal stromal cells

Cytotherapy

Volumn 9, Issue 3, 2007, Pages 301-302

  McNiece, I ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; CD11B ANTIGEN; CD14 ANTIGEN; CD19 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD79A ANTIGEN; ENDOGLIN; HLA DR ANTIGEN; THY 1 ANTIGEN;

ADIPOCYTE; ADIPOSE TISSUE; ANTIGEN EXPRESSION; CARTILAGE CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL TYPE; ENGRAFTMENT; HEART INFARCTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; LETTER; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPOTENT STEM CELL; NONHUMAN; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; STROMA CELL; UMBILICAL CORD BLOOD;

EID: 34248217546     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240701218540     Document Type: Letter

References (5)

1. Dominici, M., Blanc, K Le and Mueller, I. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8, pp. 315-317.
2. Wollert, KC, Meyer, GP and Lotz, J. (2004) Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet, 364, pp. 141-148.
3. Drexler, H., Meyer, GP and Wollert, KC (2006) Bone-marrow-derived cell transfer after ST-elevation myocardial infarction: Lessons from the BOOST trial. Nat Clin Pract Cardiovasc Med Mar, 3, p. S65.
4. Amado, LC, Schuleri, KH and Saliaris, AP (2006) Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. J Am Coll Cardiol, 48, pp. 2116-2124.
5. Ohnishi, S., Yanagawa, B. and Tanaka, K. (2007) Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis. J Mol Cell Cardiol, 42, pp. 88-97.